Dr. Hien D. Pham, MD

Dr. Pham practices at Windsor Quail Valley Post-Acute Healthcare in Missouri City, Texas.

Dr. Pham's NPI, 1003839754, was assigned on July 25, 2006. Dr. Pham graduated from UTMB Health in 2003. Dr. Pham holds Texas license M8918.

Dr. Pham's primary practice is Windsor Quail Valley Post-Acute Healthcare, at 3640 Hampton Dr, Missouri City, TX 77459 in Fort Bend County. The practice phone is (281) 778-5144.

Dr. Pham's primary practice is Windsor Quail Valley Post-Acute Healthcare in Missouri City, Texas. The medical group on file is Colleagues in Wound Care. Dmand AI also links Dr. Pham to 1 more skilled nursing facility, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pham practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Pham's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Pham is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Pham's licenses on file in 3 states: Texas, California and Louisiana.

Dmand AI lists chronic skin ulcer, lymphedema, mobility impairment, pressure ulcers and varicose veins among the conditions Dr. Pham treats.

CMS data shows 3,754 Medicare services from Dr. Pham across 11 procedure codes in 2024, for 449 Medicare patients. Medicare paid $230,779 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 449 Medicare patients who saw Dr. Pham in 2024. The largest group is 85 and over, with 169 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 56% are also on Medicaid. Their average risk score is 3.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pham's median patient age at 78, with 54% women.

In 2024, Dr. Pham wrote 69 Medicare Part D claims. 75% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $122 in total drug cost. In 2020, CMS named 35 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Pham for performance year 2024, reported individually. Dr. Pham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 796 procedures of removal of tissue by Dr. Pham, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Pham, published from 2009 to 2011. Dr. Pham's most frequent co-authors are Sheela S. Kapre, MD, Mersadies R. Martin, MD and Deepak K. Shrivastava, MD.

CMS Open Payments shows 3 general payments to Dr. Pham from 3 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $124.

Dr. Pham graduated from UTMB Health in 2003.

Dr. Pham is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.